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Abstract 
A putative membrane-interacting domain of CTP:phosphocholine cytidylyltransferase (CT) was identified using two peptide-specific antibodies. 
One antibody (SA2) was raised against he N-terminus of CT (amino acid residues l-17) and the other antibody (SA209) against an a-helical domain 
of the enzyme (amino acid residues 247-257). Both antibodies quantitatively immunoprecipitated CT from rat liver cytosol and showed speciticity 
towards CT when octylglucoside xtracts of rat liver cytosol were assessed by Western blot analysis. However, further experiments revealed that the 
antibodies had different characteristics. Whereas the antibody directed against the N-terminus of CT (SA2) did not influence CT/membrane 
interaction, the new antibody (SA209) against he cc-helical domain of the enzyme interfered with this interaction. Our results provide experimental 
evidence that the u-helical domain (amino acid residues 228-287) of CT may serve as a membrane-interacting domain. 
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1. Introduction 
In mammals, CTP:phosphocholine cytidylyltrans- 
ferase (EC 2.7.7.15) (CT) is the rate-limiting enzyme in 
the biosynthesis of phosphatidylcholine (PC) via the 
CDP-choline pathway [14]. Its activity is regulated by 
translocation of the enzyme between membranes (active 
form) and cytosol (inactive form) [5]. Regulation of the 
translocation process by changes in the lipid composition 
of cellular membranes seems to be one of the major 
mechanisms for the control of PC biosynthesis [6-141. To 
investigate the translocation process of CT in more detail 
antibodies were produced using tryptic fragments of CT 
as the immunogen [15]. Furthermore, two peptide-spe- 
cific antibodies against different domains of CT were 
introduced [16,17]. Recently, the cDNA for rat liver CT 
was cloned and sequenced. The sequence did not contain 
any signal for covalent linkages to lipids or any hydro- 
phobic domains necessary for a membrane-spanning 
helix. Only an extensive amphipathic a-helix (amino acid 
residues 22%287), which contains three 11-mer repeats 
in tandem, could serve as a membrane interacting do- 
main [18]. 
To test this hypothesis, we used a peptide-specific an- 
tibody against one part of the postulated membrane- 
binding domain (amino acid residues 247-257). In the 
present study, we investigated CT/membrane interaction 
by using this peptide-specific antibody in two experimen- 
tal systems, the indirect membrane interacting sandwich 
ELISA and the activation of purified CT by liposomes. 
Both systems showed that the antibody against amino 
acid residues 247-257 (SA209) influenced CT/membrane 
interaction. Our results confirm the hypothesis that the 
amphiphathic a-helix represents the membrane-binding 
domain of CT. 
2. Materials and methods 
2.1. Materials 
*Corresponding author. Fax: (49) (30) 798 4141. 
[methyp4C]Phosphocholine (2.04 GBq/mmol) and the ECL im- 
munoblotting detection reagent were from Amersham (Braunschweig, 
Germany). The BCA kit for protein determination was from Pierce 
(Weiskirchen, Germany). Phosphatidylcholine, oleic acid, octylgluco- 
pyranosid, m-maleimidobenxoyl-N-hydroxysuccinimide est r, phenyl- 
enediamine and protein A-Sepharose were obtained from Sigma 
(Miinchen, Germany). Peroxidase-conjugated swine anti-rabbit anti- 
body was from Dakopatts (Hamburg, Germany) and the nitrocellulose 
membrane (0.45 pm) was from Schleicher & Schtill (Dassel, Germany). 
Silicagel 60 high-performance thin layer chromatography plates and 
reagents were purchased from Merck (Darmstadt, Germany). For 
quantitication of radioactivity a thin-layer chromatography scanner 
(Berthold LB2821 HR, Wildbad, Germany) was used. 
Abbreviations: BCA, bicinchoninic acid; BSA, bovine serum albumin; 
CT, CTP: phosphocholine cytidylyltransferase; ECL, enhanced chemi- 
luminescence; ELISA, enzyme-linked immunosorbent assay; PBS, 
phosphate-buffered saline; PC, phosphatidylcholine; SA2, polyclonal 
peptide-speci6c antibody against cytidylyltransferase residues 1-17; 
$4209, polyclonal peptide-specific antibody against cytidylyltrans- 
ferase residues 247-257; SD., standard deviation. 
2.2. Peptiak synthesis and characterization 
The peptide MDAQSSAKVNSRKRRKE (CT peptide l-17), corre- 
sponding to the amino-terminal 17 amino acids of rat liver CT, and the 
peptide DKVKKKVKDVE (CT peptide 247-257), corresponding to 
amino acids 247-257 of rat liver CT, both with a cysteine added for 
coupling to a carrier, were synthesized by automated solid-phase pep- 
tide synthesis (Model 431A, Applied Biosystems, Weiterstadt, 
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Germany) using 9-fluorenyhnethoxycarbonyl (Fmoc) chemistry with 
[2-(l-H-benxotriaxol-l-yl)-l,l,3,3-tetramethyl-uronium hexafluoro- 
phosphate] (HBTU) activation of amino acids. The purity of the pep- 
tides was assessed on an analytical reverse-phase column (Eurospher 
80 C 18, 5 pm; Knauer S&rlentechnik, Berlin, Germany). A 60&n 
linear gradient from 0 to 30% acetonitrile was used for separation and 
the absorbance at 215 mn was monitored. The purity of the peptides 
was > 90%. 
The peptides were coupled to keyhole limpet hemocyanin, through 
their additional cysteine residues with m-maleimidobenxoyl-N-hydrox- 
ysuccinimide ster as described [17]. 
2.3. Antibody prhduction 
Antibodies against CI peptide 1-17 (SA2) and against CT peptide 
247-257 (SA209) were nrenared bv Euroaentec (Seraina. Belaium) 
using a standard’protocoi [l-6]. Brieiy, the s-pthetic peptidi fragments 
of CT conjugated with keyhole limpet hemocyanin (1,OOO~g each) were 
injected at several sites into two rabbits, initially with complete 
Freund’s adjuvant followed by injection of peptide conjugates (500 pg 
each) in incomplete Freund’s adjuvant every 2 weeks. 10 days after the 
third booster injection the blood of the two rabbits was taken and sera 
were obtained by centrifugation at 8,000 x g for 20 min. 100 ~1 aliquots 
of the sera were stored at -2O’C. 
Preimmune sera were taken from the rabbits before they were immu- 
nixed with CT neutide 1-17 or with CT nentide 247-257 and likewise 
1 1 
stored at -2O’C. In the experiments of & study, preimmune serum 
of the rabbit which was immunized with CT peptide 247-257 was used 
as a negative control. 
2.4. Purification of rat liver cytidylyltramferase 
CT was partially purified from rat liver cytosol as described [191 using 
acetic acid precipitation, octylglucoaide extraction followed by hydrox- 
ylapatite column chromatography. Purified CT was stored at -70°C. 
2.5. Cytidylyltransf~ase assay 
Prior to determination of CT activity, 50 ~1 of purilied enzyme 
preparation and 50 pl of rabbit serum SA2, rabbit serum SA209 or of 
preimmune serum were mixed and incubated for 3 h at 4°C. 50 ~1 buBer 
(50 mM Ttis-HCl, pH 7.4,lOO mM NaCl, 10 mM MgClJ was used as 
a control. Then, CT activity was measured by a modilied method of 
Sohal and Cornell [20]. The reaction mixture contained 50 mmolll 
Tris-HCl, pH 7.4, 0.03% Triton X-100, 100 mmol/l NaCl, 10 mmol/l 
MgCl,, 3 mmol/l CTP, 1.5 mmol/l [merhyZ-‘4C]phosphocholine (sp c. 
act. 20 Bq/runol), liposomes (0.4 mM oleic acid/O.4 mM PC) and 10 ~1 
of enzyme preparation in a 8nal volume of 55 ~1. After incubating for 
30 min at 37°C the reaction was stopped by freezing the samples in 
liquid nitrogen. The samples were lyophilized, dissolved in 20 ~1 meth- 
anol/water (1: 1, v/v) and applied to high-performance thin layer chrom- 
atography plates. After developing the plates in a solvent system con- 
taining methanoY0.6% NaCl/25% aqueous NHs (8: 5 : 1, by vol.), the 
radioactivity was determined by radioscanning. One unit of enzyme 
activity is defined as 1 mnol of GDP-choline formed per min. 
2.6. Immunoprecipitation of cytidylyltramferase 
Immunop&ip~tation of-CT from rat liver cytosol was performed as 
described 1161. Brieflv. 100 ul cvtosol was incubated for 2 h at 4°C with 
different volt&es dihe Sk2 &d SA209 sera or preimmune serum as 
control. 5 mg of protein A-Se&arose was added to each sample to 
precipitate the CT-antibody complexes, and the samples were incu- 
bated overnight at 4°C. The protein A-Sepharose was sedimented at 
13,000 x g for 2 min and CT activity in the supernatant was assessed 
as described above. 
2.7. Immunoblotting 
30 ~1 of the oct&lucoside extract of rat liver cytosol or 10 ~1 of 
ouritied CT were mixed with SDS samnle buffer and senarated by 10% 
SDS-PAGE [21]. After transfer to nitr&ellulose membrane the blot was 
incubated with 5% non-fat dry milk in PBS for 1 h at room temperature 
to block non-speci6c binding. The membrane was incubated with serum 
SA2 (1: l,OOO), serum SA209 (1: 1,000 or 1: 3,090) or preimmune serum 
(1: 1,000) in PBS containing 0.1% I&en-20 overnight at 4°C. After 
washing with PBSfIween-20 three times for 5 min, bound antibody was 
detected using horseradish peroxidase-conjugated anti-rabbit immun- 
globulin antibodies and the ECL detection reagents according to the 
manufacturer’s instructions. 
2.8. Indirect membrane interacting sandwich ELISA 
The ELISA technique was performed essentially as described [22]. 
100~1 of antibody SA2 (1: 500 in PBS) were incubated in 96 well ELISA 
plates for 1 h at 37°C and fixed with 0.25% glutardialdehyde for an- 
other 30 min at room temperature. After washing with PBS, the wells 
were saturated with PBS alone, PBS/O.O5% ‘Dveen-20 or PBS/l% BSA 
to block non-specific binding. The wells were incubated with different 
concentrations of rat liver cytosol in a total volume of 2OOpl overnight 
at 4°C. After washing, wells were incubated for 1 h at 37°C with 
liposomes (0.2 mM ok& acid/O.2 mM PC in H,O) or H,O as a control. 
Then. CT was detected usina SA209 antibodv: CT was incubated for 
1 h at 37°C with 100 ~1 of gA209 antibody ii: 250 in PBS, 1: 250 in 
PBS/0.05% Tween-20 or 1: 250 in PBS/l 95 BSA as described above) in 
the presence or in the absence of liposomes followed by incubation for 
1 h at 37°C with a peroxidase-conjugated swine anti-rabbit antibody 
(1: 2,000 in PBS). The wells were thoroughly washed and the amount 
of peroxidase-conjugated swine anti-rabbit antibody was assessed using 
200 ~1 substrate solution (0.8 mg/ml phenylenediamine, 0.015% H202 
in 0.1 M citrate buffer, pH 6.0). After 10 min at 37°C the reaction was 
stopped with 50 ~1 1.25 M sulfuric acid and the absorbance was meas- 
ured at 492 mn. The specific absorbance of each sample (E&I was 
calculated as the difference between the absorbance in the presence and 
the absorbance in the absence of rat liver cytosol. The assay was linear 
in the range of 10-100 ~1 of cytosol. 
In some experiments, the SA209 antibody was coated to the wells and 
the SA2 antibody was used to detect antibody SA209-bound CI in the 
presence or in the absence of liposomes. 
2.9. Other procedures 
Rat liver cytosol was prepared by sequential centrifugation of the 
homogenate of 10 g liver in 50 ml buffer A (50 mM Tris-HCl, pH 7.4, 
150 mM NaCl, 1.0 mM EDTA, 2.0 mM dithiothreitol, 0.025% sodium 
axide) at 10,000 x g for 20 min and 100,000 x g for 60 min. The protease 
inhibitor, phenylmethylsulfonylftuoride, was added to achieve a 1.0 
mM final concentration. Liposomes were prepared as described [20] by 
sonication for 3 min at 4’C using a 375 W sonicator (Heat Systems, 
Plainview, NY, USA) at 20% power output. Vesicles prepared in this 
way were small and unilamellar [20]. Protein was determined by the 
BCA assay [23] using BSA as standard. Statistical comparisons were 
made in these studies by Student’s t-test. 
3. Results and discussion 
3.1. Characterization of the antibodies 
To characterize the new antibody against amino acid 
residues 247-257 of CT (SA209) Western blots of 
octylglucoside xtracts of rat liver cytosol were analysed. 
Fig. 1 shows that the SA209 antibody in dilutions of 
1: 1,000 and 1:3,000 specifically reacts with CT. As a 
positive control we used the antibody against amino 
acids 1-17 of CT (SA2) as described by Watkins and 
Kent [17j. The SA2 antibody is not as specisc as the 
SA209 antibody. Especially, an additional 50 kDa pro- 
tein is detected (Fig. 1). This is in accordance with results 
using another antibody against amino acids 1-17 of CT 
that was made available by Dr. C. Kent (Ann Arbor, 
USA) (data not shown). 
Recently, the nuclear localization of CT was reported 
using this antibody against amino acids 1-17 of CT [24], 
and there exists some controversy about the hypothesis 
that most of the enzyme resides in the cytosol [25]. Be- 
cause of its specificity, the SA209 antibody will be a 
useful tool to immunolocalize CT by electron micros- 
COPY *
The SA209 antibody quantitatively precipitated 
T. Me&r et al. IFEBS Letters 345 (1994) 207-210 209 
a 
la3 - 
b 
116- 
94- 
66- 
Fig. 1. Western blot analysis of cytidylyltransferase. Proteins obtained 
from the partially pm&d preparation of CT after hydroxylapatite 
column chromatography (a) or octylglucoside extraction (b) were sepa- 
rated on 10% SDS-gels and subjected to Western blot analysis as de- 
scribed in section 2. The blots were probed with either SA2 serum 
(1: l,OOO), SA2O9 serum (1: 1,000 and 1: 3,000) or preim- 
mune serum as indicated in the figure. 
from rat liver cytosol (Fig. 2). There seemed to be a 
substantial activation of CT at lower amounts of added 
serum. However, this effect was not significant (P c 0.2). 
In contrast, the addition of 50 ~1 or 100 ~1 preimmune 
serum to rat liver cytosol did not intluence CT activity 
in the supernatant after precipitation of antibodies with 
protein A-Sepharose. Similar results were obtained 
using the SA2 antibody (data not shown). 
3.2. Measurement of cytidyIyltransferase/membrane 
interaction by sandwich ELISA technique 
The interaction of CT with membranes was investi- 
gated using liposomes in a sandwich ELISA. CT from 
rat liver cytosol was bound to SA2 antibody coated to 
microtitre wells. Then, CT was detected with SA209 an- 
Table 1 
Influence of SA2 and SA209 antibodies on liposome-activated cyti- 
dylyltransferase activity 
Pre-incubation Activation of CT (%) 
Buffer (control) 147 + 16 
Serum sA2 134 + 14 
Serum SA209 91+ 5* 
Preimmune serum 131 + 6 
CT (50 ~1) partially purilied by hydroxylapatite chromatography from 
rat liver cytosol was pre-incubated for 3 h at 4°C with 50 ~1 of SA2 
serum, 50 pl of SA209 serum, 50 pl of preimmune serum or 50 ~1 of 
buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 10 mM MgClJ as a 
control. Then, CT activity of the different probes was measured in the 
presence of liposomes (0.4 mM oleic acid, 0.4 mM PC). The values are 
given in % activation of unstimulated CT (in the absence of liposomes) 
and were calculated as [(stimulated CT activity)-(unstimulated CT 
activity)] x [lOO/(unstimulated CT activity)]. The data represent he 
mean of three determinations f S.D. Unstimulated CT activity was 
3.45 f 0.7 U/ml and stimulated CT activity under control conditions 
was 8.53 k 0.9 U/ml. *Significantly different from controls at P < 0.01. 
tibody and a peroxidase-conjugated swine anti-rabbit 
antibody. As shown in Fig. 3, the binding of SA209 was 
significantly reduced in the presence of liposomes (0.2 
mM oleic acid, 0.2 mM PC). When non-specific binding 
was blocked with PBS or with PBS/O.OS% Tween-20 
there was a reduction of the signal by 90% and 45%, 
respectively, as compared with controls. The reduced 
binding of SA209 indicates that the epitope represented 
by amino acids 247-257 is masked in the presence of 
liposomes, supposedly by specific binding of these li- 
posomes to the a-helical domain. On the other hand, 
when non-specific binding was blocked with PBS/l% 
BSA the binding of antibody SA209 was not affected. 
This is not surprising since it has been reported that oleic 
acid-stimulated translocation of CT to membranes is re- 
versed by the addition of excess BSA [24,26]. 
In another set of experiments, CT was bound to SA209 
antibody coated to microtitre wells and detected with 
antibody SA2. As shown in Fig. 3, the detection of CT 
with antibody SA2 was not influenced by liposomes, 
indicating that the effect of oleic acid-containing li- 
posomes is not due to non-specific interactions with the 
surface of the protein. 
With higher concentrations of lipid activators, e.g. 
concentrations of 1 mM oleic acid/l mM PC, the effect 
of liposomes on the detection of CT, as assessed by the 
sandwich ELISA technique, was no longer specific for 
the SA209 antibody (data not shown). 
3.3. Inhibition of liposome-stimulated 
cytidylyltransferase activity 
In a different approach to investigate the CT/mem- 
1 
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Fig. 2. Immunoprecipitation of cytidylyltransferase from rat liver cy- 
tosol. 100~1 of rat liver cytosol were incubated with increasing amounts 
of SA209 serum or preimmune serum in a tinal volume of 200 ~1. Then, 
CT was precipitated as described in section 2 and the remaining CT 
activity in the supematant was measured. Bach point represents the 
mean of three determinations ? S.D. 
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Fig. 3. Cytidylyltransferase/membrane int raction determined by sand- 
wich ELISA technique. 50,ul of rat liver cytosol were used in a sandwich 
ELISA as described in section 2. CT was detected using SA209 anti- 
body (1: 500) or SA2 antibody (1: 500) in the absence (control) or in 
the presence of liposomes (0.2 mM oleic acid/O.2 mM PC). The assay 
was performed under different blocking conditions (PBS, PBS/0.05% 
Tween-20 or BPS/l% BSA) as indicated in the figure. The data repre- 
sent the mean of three determinations f SD.; *significantly different 
from controls at P C 0.02; **significantly different from controls at 
P < 0.001. The experiment was repeated, and similar results were ob- 
brane interaction, purified CT was pre-incubated with 
SA2 serum, SA209 serum, preimmune serum or buffer 
(50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 10 mM 
MgCld as a control. Afterwards, CT was activated using 
liposomes (0.4 mM oleic acid/O.4 mM PC). Only pre- 
incubation with SA209 serum significantly reduced acti- 
vation of CT by liposomes (Table 1). Interestingly, the 
SA209 antibody inhibited the activation of CT by li- 
posomes but did not affect the basal activity of unstimu- 
lated CT (data not shown). 
In conclusion, our data substantiate the hypothesis of 
Kahnar et al. [ 181 that an unbroken a-helix from Lys-228 
to Glu-287, or a part thereof, may constitute the mem- 
brane-binding domain of rat liver CT. During the prepa- 
ration of this manuscript, the membrane-binding domain 
of CT was further characterized using chymotryptic pro- 
teolysis [27]. The data presented were fully consistent 
with our findings. In this context, the SA209 antibody, 
which is directed against CT-peptide 247-257, will be a 
useful tool to investigate the interaction of CT with mem- 
brane lipids. 
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